IE
XENT

Israel Englander’s Intersect ENT, Inc XENT Stock Holding History

Israel Englander’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-30,000
Closed -$965K – 4645
2019
Q1 		$965K Buy
+30,000
New +$928K ﹤0.01% 2887

Israel Englander's XENT Position: Q2 2022 in Review

Israel Englander sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 510,536 shares — an estimated $14.3M sold.

Israel Englander first reported a position in XENT in Q3 2014 and held it in 25 quarters. The position peaked at $43.1M in Q1 2019. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Israel Englander reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Israel Englander sold 510,536 Intersect ENT, Inc shares in Q2 2022, an estimated $14.3M.
  • Israel Englander first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 25 quarters.
  • Israel Englander's Intersect ENT, Inc position peaked at $43.1M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.